Assessing a new scoring system for diagnosing heart dysfunction in patients with high blood pressure
Official title: Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension
Run by Universitas Diponegoro · NCT06779513 · Data updated 2026-11-12
This study is testing a new scoring system to see if it can help doctors diagnose heart problems in people with high blood pressure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Universitas Diponegoro Academic / other |
| Locations | 1 site (Semarang, Central of Java) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 31, 2024 |
| Study ends | March 15, 2025 |
| Registry record updated | January 16, 2025 |
| Trial ID | NCT06779513 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with essential hypertension.
✕Probably not a fit
Patients with secondary or resistant hypertension, or those with significant heart conditions, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to validate a novel Morphology-Voltage-P-wave Score (MVP Score) for diagnosing left ventricular diastolic dysfunction in patients suffering from hypertension. Researchers will gather demographic, clinical, laboratory, and echocardiographic data from participants who have undergone transthoracic echocardiography. The collected data will be analyzed using IBM SPSS Statistics v26 to determine the effectiveness of the MVP Score in identifying heart dysfunction. The study focuses on patients with essential hypertension while excluding those with various heart conditions.
Why it matters
Potential benefit: If successful, this study could provide a more accurate diagnostic tool for identifying heart dysfunction in hypertensive patients, leading to better management and treatment.
How similar studies have gone: While similar diagnostic approaches have been explored, the MVP Score represents a novel method that has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Essential hypertension Exclusion Criteria: * Secondary or resistant hypertension * LVEF\<55% * Congenital heart disease * Infiltrative cardiomyopathy * Coronary artery disease * Chronic kidney disease * Valvular heart disease * Bundle branch block * Arrhythmia
Where it's running
-
Dr. Kariadi Central General Hospital
Semarang, Central of Java, Indonesia Recruiting
Study contacts
- Study coordinator: Leo Deddy Pradipta
- Email: dancingdeagle@gmail.com
- Phone: +6281316499074
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.